CHINA PHARMA HOLDINGS, INC. Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed of 82.00% for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed · last filed 2024-11-13
- CHINA PHARMA HOLDINGS, INC. debt instrument, redemption price, percentage of principal amount redeemed for fiscal 2023 was 82.00%.
| Period end | Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed 6 month | Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed 9 month | Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed 12 month |
|---|---|---|---|
| 2024-06-30 | 82.00% 10-Q · filed 2024-08-14 | ||
| 2023-12-31 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-09-30 | 82.00% 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |